Paper Details

  1. Home
  2. Paper Details

A general practice evaluation of pivmecillinam given twice daily as a treatment for acute urinary tract infection.

Author: SheldonM G, SkinnerJ L, VenablesT L

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Pivmecillinam, a drug used to treat acute urinary tract infections, was effective in 38 of 38 patients in the lower dose group (200 mg twice-daily) and 22 of 26 patients in the higher dose group (400 mg twice-daily). Both doses led to a significant reduction in symptom scores. Side effects were reported in 7 (4%) patients in the lower dose group and 11 (10%) patients in the higher dose group.
Paper Details　
Original Abstract of the Article :
In a multi-centre study in general practice, 292 female patients with acute urinary tract infection received a 5-day course of pivmecillinam at a dosage of either 200 mg or 400 mg twice-daily. Positive bacteriological cultures were obtained from 64 (31%) of 206 patients for whom bacteriological data...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6504945

データ提供：米国国立医学図書館（NLM）

Pivmecillinam: A Twice-Daily Journey Through Urinary Tract Infections

Imagine the urinary tract as a complex system of canals, essential for maintaining a healthy body. This study investigates the effectiveness of pivmecillinam, an antibiotic, in treating acute urinary tract infections (UTIs). The study examined the efficacy and safety of pivmecillinam administered twice daily, exploring its potential as a convenient and effective treatment option for UTIs.

Pivmecillinam: A Twice-Daily Trek Through UTI Treatment

The study found that pivmecillinam, administered twice daily, was effective in treating acute UTIs, demonstrating a high cure rate in patients with positive bacterial cultures. This suggests that pivmecillinam can efficiently clear the infection from the canals of the urinary tract, leading to symptom relief. The study also highlighted the generally good tolerability of pivmecillinam, with minimal side effects observed.

Navigating UTIs: A Journey Towards Health and Comfort

This study underscores the importance of having effective treatment options for UTIs, a common and often uncomfortable condition. Pivmecillinam, with its twice-daily administration, provides a convenient and potentially effective approach to managing these infections. This study emphasizes the importance of finding treatment solutions that promote comfort and ease the burden of illness, allowing individuals to continue their journey towards a healthier state.

Dr.Camel's Conclusion

This study reminds us that even in the vast desert of urinary tract infections, there are effective treatments available. Pivmecillinam, with its twice-daily regimen, offers a potentially effective and convenient approach to managing these infections. The study also underscores the importance of finding treatment solutions that minimize side effects, allowing individuals to navigate the desert of illness with greater ease and comfort.

Date :
  1. Date Completed 1985-01-04
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

6504945

DOI: Digital Object Identifier

6504945

Related Literature

Article Analysis
・Side Effects of pivmecillinam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.